ESB
TEVA icon

Essex Savings Bank’s Teva Pharmaceuticals TEVA Stock Holding History

Essex Savings Bank’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-14,770
Closed -$461K – 323
2025
Q4 		$461K Sell
14,770
-1,300
-8% -$32K 0.1% 178
2025
Q3 		$325K Sell
16,070
-700
-4% -$12.3K 0.07% 212
2025
Q2 		$281K Hold
16,770
– – 0.07% 227
2025
Q1 		$258K Buy
16,770
+2,000
+14% +$35.7K 0.06% 236
2024
Q4 		$325K Hold
14,770
– – 0.08% 202
2024
Q3 		$266K Hold
14,770
– – 0.07% 236
2024
Q2 		$240K Hold
14,770
– – 0.06% 232
2024
Q1 		$154K Hold
14,770
– – 0.04% 260
2023
Q4 		$154K Buy
14,770
+3,770
+34% +$35.2K 0.04% 260
2023
Q3 		$112K Hold
11,000
– – 0.04% 225
2023
Q2 		$82.8K Hold
11,000
– – 0.03% 227
2023
Q1 		$97.3K Sell
11,000
-3,000
-21% -$29.7K 0.03% 223
2022
Q4 		$128K Sell
14,000
-682
-5% -$5.95K 0.04% 219
2022
Q3 		$118K Hold
14,682
– – 0.05% 205
2022
Q2 		$110K Hold
14,682
– – 0.04% 212
2022
Q1 		$138K Buy
+14,682
New +$123K 0.05% 221
2019
Q3 		– Sell
-400
Closed -$4K – 558
2019
Q2 		$4K Hold
400
– – ﹤0.01% 710
2019
Q1 		$6K Hold
400
– – ﹤0.01% 547
2018
Q4 		$6K Buy
+400
New +$8.2K ﹤0.01% 556

Other funds holding TEVA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $20.6B AUM 59.59% 1-Year Est. Return
PF
Phoenix Financial Givatayim, Israel $14.6B AUM 57.48% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $25.6B AUM 50.04% 1-Year Est. Return
WCM Investment Management
WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $22.3B AUM 79.91% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
LIM
Lingotto Investment Management London, United Kingdom $4.67B AUM 70.24% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Essex Savings Bank's TEVA Position: Q1 2026 in Review

Essex Savings Bank sold out of Teva Pharmaceuticals (TEVA) in Q1 2026, closing a stake of 14,770 shares — an estimated $461K sold.

Essex Savings Bank first reported a position in TEVA in Q4 2018 and held it in 19 quarters. The position peaked at $461K in Q4 2025. 651 funds tracked by Wall St. Rank hold TEVA as of Q1 2026.

  • Essex Savings Bank reported no remaining Teva Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Essex Savings Bank sold 14,770 Teva Pharmaceuticals shares in Q1 2026, an estimated $461K.
  • Essex Savings Bank first reported a position in Teva Pharmaceuticals in Q4 2018 and held it in 19 quarters.
  • Essex Savings Bank's Teva Pharmaceuticals position peaked at $461K in Q4 2025.
  • 651 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q1 2026.

Based on Essex Savings Bank's 13F filing for Q1 2026, filed 17 Apr 2026.